4-AcO-DET
4-AcO-DET is a synthetic psychedelic of the tryptamine class1, first synthesized by Albert Hofmann at the Sandoz laboratory in 1958. It is chemically related to psilocin and belongs to a series of substituted tryptamines that includes 4-AcO-MET and 4-AcO-DMT. Its effects are generally compared to those of psilocybin mushrooms.2 It remains a lesser-known research chemical, typically encountered as a slightly off-white powder and most commonly administered orally.
Dosage & Duration
Dosage
Duration
Subjective Effects
Effects vary widely by individual, dose, and context.
Physical
Cognitive
Visual
Auditory
Pharmacology
Pharmacodynamics
4-AcO-DET is hypothesized to act principally as a prodrug for 4-HO-DET, its deacetylated counterpart3, though there is ongoing discussion as to whether the acetylated compound may also display intrinsic activity of its own.3 The psychedelic effects are thought to stem primarily from 5-HT2A receptor partial agonism.4 Very little data exists on the human pharmacology of 4-AcO-DET.
Pharmacokinetics
4-AcO-DET is expected to be rapidly hydrolyzed into the free phenolic 4-HO-DET by serum esterases3, though human studies confirming the metabolic fate of this compound are lacking.
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Serotonergic psychedelics
Harm Potential
Addiction & Dependence
Psychosis Risk
Delusions are listed as a potential cognitive effect during intoxication, but no systematic data exists on intrinsic psychosis risk.
Seizure Risk
No intrinsic seizure risk has been documented for this substance.
History & Culture
4-AcO-DET was first synthesized in 1958 by Albert Hofmann at the Sandoz laboratories in Switzerland. Despite this early synthesis, the compound remained largely unexplored for decades and has accumulated very little documented history of human usage.2…
Trip Reports
Loading related reports
Preparing section content
Still loading. Refresh if this section does not appear.
Legality
International
4-AcO-DET is not listed in the current schedules of the 1961 Single Convention or the 1971 Convention on Psychotropic Substances, or in Tables I and II of the 1988 Convention.
By Country
References
Source Pages
Citations
- Clinton E. Canal, & Kevin S. Murnane. (2017). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology, 31(1), 127-143. https://doi.org/10.1177/0269881116677104123
- 4-Acetoxy-DET (Chemical Vault summary). Erowid (n.d.). https://erowid.org/chemicals/4_acetoxy_det/4_acetoxy_det.shtml12
- Toad. (2001). 4-acetoxy-DET Primer. Entheogen Review, 10(3). https://erowid.org/chemicals/4_acetoxy_det/4_acetoxy_det_primer.shtml1234
- David E. Nichols. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355. https://doi.org/10.1124/pr.115.01147812
- Matthew W. Johnson, Roland R. Griffiths, Patrick H. Hendricks, & Jack E. Henningfield. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 142, 143-166. https://doi.org/10.1016/j.neuropharm.2018.05.0121
- Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, Annex IVa. famhp.be (n.d.). https://www.famhp.be/sites/default/files/content/INSP/NARC/annex%20IV_non%20official%20consolidated%20version.pdf1
- Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, Annex IVa. ejustice.just.fgov.be (n.d.). https://www.ejustice.just.fgov.be/eli/arrete/2017/09/06/2017031231/justel1
- Portaria SVS/MS No. 344/1998, List F2. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias1
- Bekendtgørelse om euforiserende stoffer (BEK nr 405 af 26. marts 2026). retsinformation.dk (n.d.). https://www.retsinformation.dk/eli/lta/2026/405/pdf1
- Betäubungsmittelgesetz (BtMG) Anlage I. (2019). https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html1
- Betäubungsmittelgesetz (BtMG) § 3 Erlaubnis. Bundesministerium der Justiz / gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/__3.html1
- 危険ドラッグの成分4物質を新たに指定薬物に指定. (2022). https://www.mhlw.go.jp/stf/houdou/0000092698.html1
- 別紙:新たに指定された指定薬物の名称 (Attachment: Names of the Newly Designated Drugs). Ministry of Health, Labour and Welfare (Japan) (2015). https://www.mhlw.go.jp/content/11126000/001620327.pdf1
- Forskrift om narkotika (narkotikaforskriften). lovdata.no (n.d.). https://lovdata.no/dokument/SF/forskrift/2013-02-14-1991
- Forskrift om narkotika (narkotikaforskriften). lovdata.no (n.d.). https://lovdata.no/forskrift/2013-12-16-15571
- Förordning (1999:58). riksdagen.se (n.d.). https://www.riksdagen.se/sv/dokument-och-lagar/dokument/svensk-forfattningssamling/forordning-199958-om-forbud-mot-vissa-halsofarliga-varor_sfs-1999-58/1
- Lag (1999:42). riksdagen.se (n.d.). https://www.riksdagen.se/sv/dokument-och-lagar/dokument/svensk-forfattningssamling/lag-199942-om-forbud-mot-vissa-halsofarliga-varor_sfs-1999-42/1
- Förordning (1999:58) om förbud mot vissa hälsofarliga varor — konsolidering SFS 2005:733. Sveriges riksdag / lagen.nu (n.d.). https://lagen.nu/1999:58/konsolidering/2005:7331
- Lag (1999:42) om förbud mot vissa hälsofarliga varor, 3 §. Sveriges riksdag / lagen.nu (n.d.). https://lagen.nu/1999:421
- Bakanlar Kurulu Kararı - Karar Sayısı : 2013/5742. (2013). https://resmigazete.gov.tr/eskiler/2014/01/20140125-3.htm1
- Kararnamenin Eki: Liste. (2014). https://resmigazete.gov.tr/eskiler/2014/01/20140125-3-1.pdf1
- Misuse of Drugs Act 1971, Schedule 2 — Class A Drugs. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/schedule/212
- 21 CFR § 1308.11 Schedule I. Cornell Law School Legal Information Institute (n.d.). https://www.law.cornell.edu/cfr/text/21/1308.111
- 21 U.S.C. § 813 — Treatment of controlled substance analogues. Cornell Law School Legal Information Institute (n.d.). https://www.law.cornell.edu/uscode/text/21/8131
Further Reading
- Reviewed & approved
Reviewed, edited, and approved by subject-matter expert Lyrea.
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 4-AcO-DET article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.